Persistence of Mutations in Complete Remission Including DNMT3A, TET2 and ASXL1 Mutations Is Associated with Worse Prognosis in Patients with Acute Myeloid Leukemia Treated in ALFA 0702 Study

Autor: Hirsch, Pierre *, Lambert, Jérôme *, Bucci, Maxime *, Deswarte, Caroline *, Lambert, Juliette *, Fenwarth, Laurène *, Dombret, Herve, Duployez, Nicolas *, Preudhomme, Claude, Itzykson, Raphael, Delhommeau, Francois *
Zdroj: In Blood 15 November 2022 140 Supplement 1:549-550
Databáze: ScienceDirect